Cargando…
Cancer Vaccines: Research and Applications
Designing cancer vaccines has been at the forefront of cancer research for over two-and-a-half decades. In particular, delivery methods used to stimulate effective and long-lasting immune responses have been the major focus. This special issue presents new tumor associated antigens, delivery methods...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721783/ https://www.ncbi.nlm.nih.gov/pubmed/31344788 http://dx.doi.org/10.3390/cancers11081041 |
_version_ | 1783448419862315008 |
---|---|
author | Apostolopoulos, Vasso |
author_facet | Apostolopoulos, Vasso |
author_sort | Apostolopoulos, Vasso |
collection | PubMed |
description | Designing cancer vaccines has been at the forefront of cancer research for over two-and-a-half decades. In particular, delivery methods used to stimulate effective and long-lasting immune responses have been the major focus. This special issue presents new tumor associated antigens, delivery methods, combination immune therapies, methods of measuring immunity induced following cancer vaccinations, and mechanisms in understanding tumor microenvironments and immunosuppression—all beneficial for the design of improved cancer vaccines. |
format | Online Article Text |
id | pubmed-6721783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-67217832019-09-10 Cancer Vaccines: Research and Applications Apostolopoulos, Vasso Cancers (Basel) Editorial Designing cancer vaccines has been at the forefront of cancer research for over two-and-a-half decades. In particular, delivery methods used to stimulate effective and long-lasting immune responses have been the major focus. This special issue presents new tumor associated antigens, delivery methods, combination immune therapies, methods of measuring immunity induced following cancer vaccinations, and mechanisms in understanding tumor microenvironments and immunosuppression—all beneficial for the design of improved cancer vaccines. MDPI 2019-07-24 /pmc/articles/PMC6721783/ /pubmed/31344788 http://dx.doi.org/10.3390/cancers11081041 Text en © 2019 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Editorial Apostolopoulos, Vasso Cancer Vaccines: Research and Applications |
title | Cancer Vaccines: Research and Applications |
title_full | Cancer Vaccines: Research and Applications |
title_fullStr | Cancer Vaccines: Research and Applications |
title_full_unstemmed | Cancer Vaccines: Research and Applications |
title_short | Cancer Vaccines: Research and Applications |
title_sort | cancer vaccines: research and applications |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721783/ https://www.ncbi.nlm.nih.gov/pubmed/31344788 http://dx.doi.org/10.3390/cancers11081041 |
work_keys_str_mv | AT apostolopoulosvasso cancervaccinesresearchandapplications |